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Abstract. 
 
We report the identiﬁcation of 
 
b
 
IV spectrin,
a novel spectrin isolated as an interactor of the receptor
tyrosine phosphatase-like protein ICA512. The 
 
b
 
IV
spectrin gene is located on human and mouse chromo-
somes 19q13.13 and 7b2, respectively. Alternative splic-
ing of 
 
b
 
IV spectrin generates at least four distinct iso-
forms, numbered 
 
b
 
IV
 
S
 
1–
 
b
 
IV
 
S
 
4 spectrin. The longest
isoform (
 
b
 
IV
 
S
 
1 spectrin) includes an actin-binding do-
main, followed by 17 spectrin repeats, a speciﬁc domain
in which the amino acid sequence ERQES is repeated
four times, several putative SH3-binding sites and a
pleckstrin homology domain. 
 
b
 
IV
 
S
 
2 and 
 
b
 
IV
 
S
 
3 spec-
 
trin encompass the NH
 
2
 
- and COOH-terminal halves of
 
b
 
IV
 
S
 
1 spectrin, respectively, while 
 
b
 
IV
 
S
 
4 spectrin
lacks the ERQES and the pleckstrin homology domain.
Northern blots revealed an abundant expression of 
 
b
 
IV
spectrin transcripts in brain and pancreatic islets. By
immunoblotting, 
 
b
 
IV
 
S
 
1 spectrin is recognized as a pro-
tein of 250 kD. Anti–
 
b
 
IV spectrin antibodies also react
with two additional isoforms of 160 and 140 kD. These
isoforms differ from 
 
b
 
IV
 
S
 
1 spectrin in terms of their
distribution on subcellular fractionation, detergent ex-
tractability, and phosphorylation. In islets, the immu-
noreactivity for 
 
b
 
IV spectrin is more prominent in 
 
a
 
than in 
 
b
 
 cells. In brain, 
 
b
 
IV spectrin is enriched in my-
elinated neurons, where it colocalizes with ankyrin
 
G
 
480/270-kD at axon initial segments and nodes of Ran-
vier. Likewise, 
 
b
 
IV spectrin is concentrated at the
nodes of Ranvier in the rat sciatic nerve. In the rat hip-
pocampus, 
 
b
 
IV
 
S
 
1 spectrin is detectable from embry-
onic day 19, concomitantly with the appearance of im-
munoreactivity at the initial segments. Thus, we suggest
that 
 
b
 
IV
 
S
 
1 spectrin interacts with ankyrin
 
G
 
 480/270-kD
 
and participates in the clustering of voltage-gated Na
 
1
 
channels and cell-adhesion molecules at initial seg-
ments and nodes of Ranvier.
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Introduction
 
The spectrins were originally identified as rod-shaped
molecules that are part of the lattice-like cytoskeleton un-
derneath the erythrocyte membrane (Marchesi and Steers,
1968; Byers and Branton, 1985; Bennett and Gilligan,
1993). This subplasmalemmal meshwork is required to
maintain the shape and lipid asymmetry of the plasma
 
membrane. The critical role of these proteins is best
revealed by the evidence that several human genetic
syndromes, such as elliptocytosis and spherocytosis,
are caused by mutant spectrin alleles (for review, see
Marchesi, 1988; Gallagher and Forget, 1998). The spec-
trins have also been proposed to participate in the traffick-
ing of organelles along the secretory pathways (Beck and
Nelson, 1998; De Matteis and Morrow, 1998), and to play
a role in regulated secretion (Goodman et al., 1995; Sikor-
ski et al., 1991, 2000).
 
The spectrin molecule is a tetramer that consists of two 
 
a
 
and two 
 
b
 
 subunits. A tight association between the NH
 
2
 
-
terminal domain of an 
 
a
 
 subunit and the COOH-terminal
domain of a 
 
b
 
 subunit forms a heterodimer, which assem-
bles into a tetramer through a head-to-head association.
The most distinctive feature of both subunits is the pres-
 
ence of multiple repeats, each consisting of 
 
z
 
106 residues
that assemble to form a three-helix bundle (Speicher and
Marchesi, 1984; Yan et al., 1993). 
 
a
 
 spectrins include 20
spectrin repeats, two of which are less conserved, an SH3
motif between spectrin repeats 9 and 11, and a COOH-ter-
minal domain with two EF-hand motifs. 
 
b
 
 spectrins, on the
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other hand, contain 17 spectrin repeats in between an ac-
tin-binding domain at the NH
 
2
 
 terminus and a pleckstrin
homology (PH)
 
1
 
 domain towards the COOH terminus.
Until recently, four genes encoding two 
 
a
 
 spectrins (
 
a
 
I
and 
 
a
 
II) and two 
 
b
 
 spectrins (
 
b
 
I and 
 
b
 
II) were known in
mammals. 
 
a
 
I
 
S
 
1 and 
 
b
 
I
 
S
 
1 spectrin are primarily expressed
in erythrocytes, whereas 
 
a
 
II 
 
S
 
1 and 
 
b
 
II
 
S
 
1 spectrin have a
wide tissue distribution and are particularly abundant in
the brain (Goodman et al., 1981; Burridge et al., 1982;
Glenney et al., 1982; Ma et al., 1993). An alternative
spliced isoform of 
 
b
 
I spectrin, termed 
 
b
 
I
 
S
 
2 spectrin is
highly expressed in muscle and brain (Riederer et al.,
1986; Zagon et al., 1986; Winkelmann et al., 1990b; Mal-
chiodi-Albedi et al., 1993). Similarly, an alternative spliced
form has been found for 
 
b
 
II spectrin (Hayes et al., 2000).
The number of 
 
b
 
 spectrins has recently expanded with the
discovery of 
 
b
 
III (Ohara et al., 1998) and 
 
b
 
V (Stabach and
Morrow, 2000) spectrin. 
 
b
 
III spectrin, which is most abun-
dant in brain and kidney, is concentrated at the Golgi ap-
paratus (Stankewich et al., 1998), and may therefore rep-
resent one of the Golgi spectrins previously reported
(Beck et al., 1994; for review, see Beck and Nelson, 1998;
De Matteis and Morrow, 1998). 
 
b
 
V spectrin is an excep-
tion among mammalian spectrins, as it includes 30 repeats,
similar to the 
 
Drosophila
 
 
 
b
 
 heavy (
 
b
 
H
 
) spectrin (Dubreuil
et al., 1990). This large spectrin is most prominent in the
outer segments of the retina and in gastric epithelial cells,
while low levels are found in many tissues.
Besides with 
 
a
 
 spectrins, 
 
b
 
 spectrins interact directly
with many additional proteins, including actin, protein 4.1,
and ankyrins (Bennett and Gilligan, 1993). Through the
association with protein 4.1, 
 
b
 
I spectrin interacts with the
membrane proteins glycophorin C and the Cl
 
2
 
/HCO
 
2
 
3
 
 ex-
changer (for review, see Conboy, 1993). The binding to
ankyrins provides 
 
b
 
 spectrins with an additional linkage to
integral membrane proteins, such as the voltage-gated
Na
 
1
 
 channel, CD44, and the Na
 
1
 
/K
 
1
 
 ATPase (Bennett
and Gilligan, 1993). Finally, 
 
b
 
 spectrins can directly associ-
ate with membrane proteins via a domain located at the
end of spectrin repeat 1 and with phosphoinositides
through the PH domain (Davis and Bennett, 1994; Lom-
bardo et al., 1994; Godi et al., 1998; Yao et al., 1999). Thus,
 
b
 
 spectrins are essential in the generation of organized cy-
toplasmic and membrane microdomains.
Here we report the cloning and characterization of a
novel human spectrin, termed 
 
b
 
IV spectrin, which was iso-
lated in a two-hybrid screening in yeast as an interactor of
the autoantigen of type I diabetes ICA512 (Rabin et al.,
1992, 1994; Lan et al., 1994). ICA512 (also known as IA-2,
PTP-35, PTPLP, and PTPN) is a receptor tyrosine phos-
phatase–like protein of unknown function, which is associ-
ated with the secretory granules of neurons and peptide-
secreting endocrine cells (Solimena et al., 1996; Lee et al.,
1998; Solimena, 1998; Hermel et al., 1999). The association
of ICA512 with 
 
b
 
IV spectrin is consistent with previous
studies suggesting that ICA512 interacts with the cytoskel-
eton (Hermel et al., 1999; Ort et al., 2000). Our data indi-
 
cate that 
 
b
 
IV spectrin is most abundant in brain and pan-
creatic islet cells and undergoes extensive alternative
splicing. In brain, 
 
b
 
IV spectrin is colocalized with anky-
rin
 
G
 
 480/270-kD at initial segments and nodes of Ranvier
of myelinated neurons, the axonal compartments responsi-
ble for the generation and regeneration of action poten-
tials. Thus, we propose that 
 
b
 
IV spectrin, in concert with
ankyrin
 
G
 
 480/270, is required for the anchoring of voltage-
gated Na
 
1
 
 channels and cell adhesion molecules to the ac-
tin cytoskeleton and may play an important role in the
physiology of nerve conduction.
 
Materials and Methods
 
Antibodies
 
b
 
IV spectrin antisera were raised against two synthetic peptides corre-
sponding to amino acids 2237–2256 (specific domain antiserum, SD) and
2542–2559 (COOH-terminal domain antiserum, CT) of human 
 
b
 
IV spec-
trin, respectively. Both peptides were coupled to keyhole limpet hemocya-
nin through an added cysteine at their NH
 
2
 
 terminus and were injected
into rabbits to generate polyclonal antisera. Both antisera were affinity
purified on their corresponding peptides that had been covalently linked
to ECH-Sepharose beads (Amersham Pharmacia Biotech). Fractions of
the antisera were eluted with 0.2 M glycine (pH 3.0), collected and dia-
lyzed with Tris buffer, pH 7.5. The specificity of these antisera and affinity
purified antibodies was tested by Western blot on Triton X-100 extracts
from COS cells expressing a partial fragment of 
 
b
 
IV spectrin (residues
2068–2559), termed B8.
The following antibodies were from commercial sources: rabbit anti–
LexA antiserum and mouse anti–V5 antibody (Invitrogen), mouse mono-
clonal antibody against ankyrin G 480/270-kD (Zymed Laboratories),
mouse monoclonal antibody against glucagon (Sigma-Aldrich), mouse
monoclonal antibody against myelin basic protein (Sternberger Mono-
clonal Antibodies), anti–rabbit and anti–mouse goat IgG antibodies con-
jugated to Alexa 488 or Alexa 568 (Molecular Probes, Inc.). A mouse
monoclonal antibody against hemagglutinin (HA) was a kind gift of R.
Collins (Cornell University, Ithaca, NY). Affinity-purified antibodies
against the cytoplasmic or the ectodomain of ICA512 have been described
previously (Solimena et al., 1996; Hermel et al., 1999).
 
Two-Hybrid Screening in Yeast
 
A yeast two-hybrid screening was executed according to the protocol of
Vojtek et al. (1993). Briefly, the cDNAs encoding the cytoplasmic do-
mains of human ICA512 (amino acids 601–979, ICA512cyt), human PHO-
GRIN (amino acids 640–1015, PHOGRINcyt) and ICA512 mutant allele
(ICA512cyt AD/DA) were amplified by PCR and subcloned into the
pLexA vector to create fusion proteins with the LexA DNA binding do-
main. The ICA512cyt AD/DA mutant was constructed using site-directed
mutagenesis on human ICA512 in pRC/RSV (Invitrogen) with the Quick-
Change mutagenesis kit (Stratagene) according to the manufacturer’s in-
structions (A877D, 5
 
9
 
 primer: CCTCAGCTGGCCGGACGAGGGCA-
CACCGG, 3
 
9
 
 primer: CCGGTGTGCCCTCGTCCGGCCAGCTGAGG;
D911A, 5
 
9
 
 primer: CGTGCACTGCTCGGCCGGTGCGGGGAG; 3
 
9
 
primer: CTCCCCGCACCGGCCGAGCAGTGCAC). The cytoplasmic
domain of human PHOGRIN was amplified by PCR from a human adult
brain cDNA library in pACT2 (CLONTECH Laboratories, Inc.). Auto-
mated sequencing of all constructs was carried out by the Keck Biotech-
nology Resource Laboratory at Yale University School of Medicine.
pLexA-ICA512cyt, pLexA-ICA512cyt AD/DA, and pLexA-PHO-
GRINcyt were independently transformed into the yeast strain L40 [par-
tial genotype MATa trp1 leu2 his3 LYS2::(lexAop)-HIS3 URA3::(lex-
Aop)-lacZ GAL4] and AMR70 [partial genotype: MAT
 
a
 
 his3 lys2 trp1
leu2 URA3::(lexAop)-lacZ GAL4]. Expression of the LexA-fusion pro-
teins (baits) in yeast cells was verified by Western blotting using the anti-
LexA antiserum (1:1,000). L40 cells expressing pLexA-ICA512cyt were
cotransformed with 500 
 
m
 
g of a human adult brain cDNA library in
pACT2 (Clontech) that included an in-frame HA tag (Clontech). Double
transformants were selected for His
 
1
 
 and LacZ
 
1
 
 phenotypes. After purg-
ing of the bait plasmid, L40 His
 
1
 
 LacZ
 
1
 
 cells were mated separately with
AMR70 cells transformed with the following baits: LexA-ICA512cyt,
LexA-ICA512cyt AD/DA, LexA-PHOGRINcyt, LexA-lamin, and LexA-
 
1
 
Abbreviations used in this paper:
 
 3-AT, 3-amino-1,2,4-triazole; CT,
COOH-terminal domain antiserum; HA, hemagglutinin; HB, homogeni-
zation buffer; HSP, high-speed pellet; HSS, high-speed supernatant; PH,
pleckstrin homology; PNS, post-nuclear supernatant; PTP, protein ty-
rosine phosphatase; SD, specific domain antiserum. 
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MSS4. Since lamin and MSS4 are proteins unrelated to ICA512, they were
not expected to share interactors with ICA512. Accordingly, only those
pACT2 plasmids that reconstituted His
 
1
 
 auxotrophy with LexA-ICA512
cyt, but not LexA-lamin or LexA-MSS4, in the mating assay were isolated
and their cDNA inserts characterized by sequence analysis. The strin-
gency conditions of the mating assay were increased by adding 3-amino-
1,2,4-triazole (3-AT) (Sigma-Aldrich) to the plate media at concentrations
ranging from 0 to 10 mM. To assess expression of bait and prey proteins in
the mating assay, diploid cells were lysed by incubation for 10 min in 0.2 N
NaOH/0.5% 
 
b
 
-mercaptoethanol on ice. Lysates were incubated with 10%
trichloroacetic acid for 30 min on ice, and then spun for 10 min at 10,000 
 
g
at 48C. After precipitation in 100% acetone, the proteins were resus-
pended in 2% SDS sample buffer (New England Biolabs, Inc.) to a final
concentration of 200–400 mg/OD. Protein concentration in tissue extracts
was determined using the BCA assay procedure (Pierce Chemical Co.).
100 mg protein from each lysate was run on 12% SDS-PAGE and blotted
with anti-HA (1:10) and anti-LexA (1:1,000) antibodies followed by 125I-
Protein A (105 cpm/ml) and autoradiography.
Cloning of bIV Spectrin
Cloning of the full length bIV spectrin cDNA from adult human brain was
performed using standard molecular procedures (Sambrook et al., 1989).
Briefly, a 325-bp fragment (6381–6705 bp in bIV spectrin) within the partial
clone isolated in the two-hybrid screening was amplified by PCR (59 primer:
AGCCGGGAGCTGGGCAGCAGCGTG and 39 primer: GGCGCA-
CATACCCCACCCGAGTCC) and labeled with [a-32P-dCTP] (3,000 Ci/
mmol; Amersham Pharmacia Biotech) using the Random Prime Labeling
Kit (Amersham Pharmacia Biotech). This probe was used to screen 2 3 106
independent phage clones of a lgt11 human brain cDNA library (Clontech)
on nitrocellulose filters. Three independent phages were isolated whose se-
quences partially overlapped that of the original clone. Six additional
screenings, each of 2 3 106 phages from a lgt10 human cerebellum cDNA
library (Clontech), yielded 20 independent phages. Contig alignment of
their inserts led to the assembly of 7,779-bp cDNA. The remaining 1,010 bp
at the 59 end bIV spectrin were cloned by PCR on a human brain Mara-
thon-Ready cDNA library (Clontech) according to the manufacturer proto-
col using the following reverse primer: 59-CTCCCGAGGCACAAAGAG-
GCGACG.
A 444-bp cDNA fragment of bIV spectrin was amplified by PCR from
mouse pancreatic islet cDNA (gift of Dr. R. Flavell, Yale University) using
the following primers: (59 primer: GGCTCAGAATAAGGAGTGGCT-
GGAGAAGAT; 39 primer: AACGGCTCGAGCAGGCGCACCAG-
GCGC). Computer-assisted analysis of all cDNAs was performed using the
following software programs: BLAST (Altschul et al., 1990), Lasergene
(DNASTAR Inc.) and PFSCAN (ISREC Bioinformatics Groups). Intron-
exon boundaries of the human bIV spectrin gene were established by com-
paring the cDNA sequence with the corresponding genomic sequence.
Chromosomal Localization
Human and mouse BAC clones encompassing the bIV spectrin gene were
isolated at Genome Systems according to established protocols (Shizuya
et al., 1992) using a fragment of the human bIV spectrin cDNA (nucle-
otides 4094–4502) as a probe. Automated sequence analysis of these
clones confirmed the presence of exon–intron boundaries within the bIV
spectrin gene. The locus of the bIV spectrin gene on human and mouse
chromosomes was also established at Genome Systems by fluorescent in
situ hybridization using human and mouse genomic probes (.10 kb) orig-
inating from the corresponding BAC clones (Stokke et al., 1995).
Expression of ICA512 and bIV Spectrin in COS Cells 
and Coimmunoprecipitations
A full-length human ICA512 construct in the mammalian expression vec-
tor pRC/RSV (Invitrogen) has been described previously (Hermel et al.,
1999). A starting methionine was introduced by PCR at the 59 end of the
bIV spectrin partial clone B8. The resulting cDNA, including the NH2-ter-
minus HA tag derived from the pACT2 cDNA library, was subcloned as a
HindIII–XbaI insert into pRC/RSV. Both ICA512 and B8 constructs (5
mg) were transiently transfected into COS cells by the Ca21-phosphate
procedure, as described previously (Dirkx et al., 1995). 72 h after transfec-
tion, transfected or mock-transfected (no cDNA) COS cells were har-
vested in PBS, pelleted, and then solubilized for 90 min on ice with homog-
enization buffer (158 mM NaCl, 10 mM HEPES, pH 7.4, 1mM PMSF, 10
mM benzamidine, 1 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin
A, 1 mg/ml antipain) including 2% Triton X-100. One confluent dish
(z1.5 3 107 cells) was used per immunoprecipitation. Insoluble material
was removed by centrifugation at 15,000 g for 10 min at 48C. Triton X-100
soluble material was precleared with 125 ml of 50% slurry protein G
sepharose beads (Amersham Pharmacia Biotech). Next, extracts were in-
cubated overnight at 48C with 10 ml of a monoclonal antibody against the
cytoplasmic domain of ICA512 or 50 ml of the bIV-SD antibody. 100 ml of
a 50% slurry protein G sepharose beads was added to each sample and in-
cubated for 1 h on ice. Beads were pelleted by centrifugation, washed
three times with 2% Triton X-100 in homogenization buffer without pro-
tease inhibitors, and then resuspended in 100 ml of 13 SDS sample buffer.
20 ml of each immunoprecipitate was separated on a 8% SDS-polyacryl-
amide gel, transferred on nitrocellulose, and immunoblotted with the fol-
lowing antibodies: anti–ICA512 ectodomain (1:1,000), anti–HA (1:10), and
anti–bIV-SD (1:250). Immunoreactivity was detected with alkaline phos-
phatase–conjugated goat anti–mouse (Sigma-Aldrich) or anti–rabbit IgG
(Roche) (1:5,000).
Northern Blotting
A nitrocellulose filter with z2 mg polyA1 RNA from various human tis-
sues (Multi Tissue Northern blot; Clontech) was hybridized with an a-32P-
dCTP–labeled probe including nucleotides 6202–6526 within the pre-
dicted open reading frame of bIV spectrin. The hybridization was per-
formed according to the manufacturer’s instructions. After x-ray exposure
for 5 d, the blot was stripped by immersion in boiling water containing
0.5% SDS and rehybridized with a probe specific for human b-actin pro-
vided by the manufacturer.
10 mg polyA1 RNA was purified with an Oligotex Direct mRNA kit
(Qiagen) from z4 3 104 human pancreatic islets kindly provided by the
JDF Human Islet Distribution Centers at the University of Miami (Miami,
FL), and Washington University (St. Louis, MO). z2 mg polyA1 RNA
was separated on a 1% agarose gel containing 5% formaldehyde, blotted
overnight on nitrocellulose by capillarity and hybridized with a probe in-
cluding nucleotides 1805–2356 in the open reading frame of human bIV
spectrin. The autoradiography was developed after a 5-d exposure.
Transfection of b-Spectrin Constructs in CHO Cells
The cDNAs encoding the carboxy termini of human bIS2, bII, bIII, and
bIVS1 spectrin were amplified by PCR using the following templates: a
partial clone of human bIS2 spectrin cDNA (Winkelmann et al., 1990b;
gift of Dr. Bertrand Forget, Yale University) (59 primer: ACCATGGAA-
GAAGAGGGAACGTGG, 39 primer: CTTCTTTTTGGGGAAGAA-
GCTGAA); the pACT2 human brain cDNA library (Clontech) for bIIS1
spectrin (59 primer: GCACCATGCGGATGGCAGAAACGGTGGAC,
39 primer: TTTCTTTTTGCCAAAAAGGCTGAACCGCTT) and bIII
spectrin (59 primer: GCACCATGGGACAACAGAGACTTGAGCAC,
39 primer: CTTGTTCTTCTTAAAGAAGCTGAA); our partial clone B8
for  bIV spectrin (GCACCATGGTGCGGCCACGACCGGAGCGC-
CAGGAG, 39primer: CTTCCTGCGCCCGCTGGCCCTGCGATCTC-
CGCCTTCCC). All cDNAs were subcloned upstream of the V5 epitope
tag into pcDNA3.1/V5-His-TOPO/lacZ (Invitrogen) and transfected into
CHO cells using the Lipofectin reagent (Life Technologies, Inc.) as de-
scribed previously (Solimena et al., 1993).
Biochemical Procedures on Human Islets and Rat
Brain Tissues
Approximately 2.5 3 104 purified human pancreatic islets were sonicated
on ice in 200 ml homogenization buffer (HB; 10 mM HEPES, pH 7.4, 5
mM EDTA, 1 mM EGTA, 1 mM NaCl, 1 mM PMSF, 10 mM benzami-
dine, 1 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin A, 1 mg/ml
antipain). The islet lysates were then solubilized in 2% SDS sample buffer
to a final protein concentration of z2.5 mg/ml. SDS insoluble material
was removed by centrifugation.
Brain tissues were collected from adult rats, 15- (E15) and 19- (E19)
d-old rat embryos and 1- (P1) and 10- (P10) d-old newborn rats. Tissues
were homogenized on ice in HB (1:10 wt/vol). Post-nuclear supernatant
(PNS) was obtained by centrifugation at 1,000 g for 10 min and solubilized
in 2% SDS sample buffer to a final concentration of z1.2 mg/ml. PNS pro-
teins (40 mg/lane) were separated by 6% SDS-PAGE and immunoblotted
with bIV-SD (1:500) or bIV-CT (1:500) antibodies, followed by peroxi-
dase-conjugated goat anti–rabbit IgG (1:5,000; Sigma-Aldrich) and en-
hanced chemiluminescence (Amersham Pharmacia Biotech). As controls,
PNS proteins from adult rat brain were blotted with the preimmune rabbit
sera as well as with bIV spectrin antibodies that had been preincubated
with 100 mg of the corresponding antigenic peptide.The Journal of Cell Biology, Volume 151, 2000 988
High-speed pellet (HSP) and high-speed supernatant (HSS) from PNS
of adult rat brain were obtained by centrifugation at 100,000 g for 1 h at
48C. The HSS was collected, while the HSP was brought back to the origi-
nal volume in HB containing 1% Nonidet P-40 (Boehringer) and 0.5%
deoxycholic acid (Sigma-Aldrich). The HSP was solubilized for 2 h at 48C
and centrifuged at 100,000 g for 1 h. After the recovery of the soluble frac-
tion, the HSP insoluble fraction was resuspended and sonicated in an
equal volume of HB. PNS, HSS, and HSP soluble and insoluble fractions
were dissolved in SDS sample buffer, separated by 6% SDS-PAGE, and
blotted with the affinity purified bIV-CT and bIV-SD antibodies.
For alkaline phosphatase treatment, adult rat brain tissue was homoge-
nized in HB without EDTA and EGTA. 300 ml of the resulting PNS (z1.8
mg/ml) was incubated with 50 U of calf-intestine alkaline phosphatase
(Roche) in phosphatase buffer for 1 h at 378C. Alternatively, subcellular
fractions of rat brain were prepared as described above, and then treated
with alkaline phosphatase before SDS-PAGE and immunoblotting.
In Situ Hybridization
35S-labeled riboprobes were prepared with a transcription kit (Promega)
using as a template a partial cDNA of bIV spectrin (bp’s 6384–8792) that
had been subcloned into pBluescript SK and KS vectors (Stratagene) as a
HindIII-XbaI fragment. The antisense and control sense cRNAs were
transcribed in the presence of 35S-UTP (Amersham Pharmacia Biotech)
from the XbaI-linearized SK plasmid and the HindIII-linearized KS plas-
mid, respectively. In situ hybridization on cryosections of rat brain (10 mm)
was performed as previously described (Dunbar et al., 1998). Dark-field
images were acquired with a microscope (BX50; Olympus) connected to
an Olympix CCD camera driven by IP-Lab Software 3.0 (Scanalytics).
Immunocytochemistry
Males Sprague-Dawley rats (150–175 g) were fixed by trans-cardiac perfu-
sion with 1% paraformaldehyde in 120 mM sodium phosphate buffer. Tis-
sues of interest were collected, fixed for an additional 3 h, and then infil-
trated with 30% sucrose in PBS. Tissues from rats at days E15, E19, and
P10 were collected, fixed in 1% paraformaldehyde for 3 h, and then infil-
trated with 30% sucrose. Teased fibers from rat sciatic nerve were pre-
pared and fixed with 1% paraformaldehyde as previously described (Fjell
et al., 2000). Single and double immunolabeling on 12-mm cryostat tissue
sections and transfected CHO cells was performed as previously described
(De Camilli et al., 1983; Cameron et al., 1991). Primary antibodies were
diluted as follows: anti–bIV-CT and anti–bIV-SD, 1:500; anti–ankyrin G
480/270, 1:25; anti–ICA512 ectodomain, 1:10; anti–glucagon, 1:200, anti–
myelin basic protein, 1:200; anti–V5, 1:200. As controls, sections were in-
cubated with the preimmune serum of the rabbit immunized with the bIV
spectrin COOH-terminal peptide (1:50) and with anti–bIV-CT antibody
that had been preincubated with the antigenic peptide. Confocal micros-
copy was performed using an MRC 1024 station (Bio-Rad Laboratories)
attached to an Axiovert microscope (Carl Zeiss, Inc.).
Results
The COOH-terminal Region of a Novel b Spectrin 
Binds the Cytoplasmic Domain of ICA512
ICA512 belongs to the receptor protein tyrosine phos-
phatase (RPTP) family, but does not display phosphatase
activity towards conventional PTP substrates, because its
cytoplasmic PTP homology domain differs in two criti-
cal residues from that of active PTPs. Specifically, in
ICA512, the catalytic aspartate of conventional PTPs is
replaced by an alanine (A877, Fig. 1 A), while an aspar-
tate (D911) rather than the obligatory alanine is present
at position 12 from the catalytic cysteine of active PTPs.
The replacement of A877 and D911 with aspartate and
alanine, respectively, is sufficient to confer PTP activity
to the corresponding ICA512 mutant (ICA512 AD/DA)
(Magistrelli et al., 1996). To gain insight into ICA512’s
function, we searched for proteins interacting with its cy-
toplasmic domain by performing a two-hybrid screening
in yeast.
L40 yeast cells were cotransformed with LexA-
ICA512cyt fused to the DNA binding protein LexA and a
human brain cDNA library fused to the Gal4 activation do-
main in pACT2 as a source for preys. Screening of 107 L40
transformants led to the isolation of z540 colonies positive
for the expression of both the reporter genes HIS3 and
b-galactosidase. One of the preys that overcame histidine
auxotrophy when expressed with LexA-ICA512cyt (Fig. 1
B) was a novel peptide of 493 amino acids whose last 149
residues were .40% similar to the COOH-terminal region
of various b spectrins. This polypeptide, termed B8 (Fig. 2
A), also bound to a PTP active mutant of ICA512cyt
(ICA512cyt AD/DA) and to the cytoplasmic domain of
the ICA512-related protein, PHOGRIN (PHOGRINcyt)
(Wasmeier and Hutton, 1996). B8, on the other hand, did
not interact with the unrelated control baits lamin and
MSS4. When the two-hybrid assay was performed in more
stringent conditions (i.e., in the presence of the HIS3 inhib-
itor 3-AT), B8 still associated with ICA512cyt, but not with
ICA512cyt AD/DA or PHOGRINcyt (Fig. 1 C). Notably,
cells expressed comparable amounts of B8 (Fig. 1 E), but
less ICA512cyt than ICA512cyt AD/DA or PHOGRINcyt
(Fig. 1 D). These data indicated that the viability of yeast
cells expressing ICA512cyt and B8 in the presence of 3-AT
was not accounted for by a higher expression of the bait
and suggests that ICA512cyt has a higher affinity for B8
than ICA512cyt AD/DA or PHOGRINcyt. Thus, the re-
placement of the two residues that prevent ICA512 from
acting as a conventional PTP was sufficient to weaken its
interaction with B8.
The ability of ICA512 to bind B8 was further investi-
gated by coimmunoprecipitations from extracts of COS
cells cotransfected with the cDNAs encoding for full-
length ICA512 and HA-tagged B8 (Fig. 1 F). In these
cells, pro-ICA512 accumulates as a triplet of z110 kD,
while the ICA512 transmembrane fragment (ICA512
TMF) generated by the cleavage of the protein’s ecto-
domain represents a minor species (Hermel et al., 1999).
Immunoprecipitation with the bIV-SD antibody raised
against a peptide within B8 followed by Western blotting
with a monoclonal anti–HA antibody allowed the detec-
tion of a single protein of z60 kD in transfected COS cells,
but not in mock-transfected COS cells. The size of this
protein corresponds to the predicted size of HA-tagged
B8. The same protein was also immunoprecipitated from
cotransfected COS cells using a monoclonal antibody di-
rected against the cytoplasmic domain of ICA512. These
data confirmed the interaction between the two proteins
revealed by the two-hybrid assay.
Cloning of Human bIV Spectrin
Screenings of human brain cDNA libraries by filter hy-
bridization and PCR allowed the contig assembly of an
8,789-bp cDNA, including a 59-untranslated region of 179
bp and a 39-untranslated region of 933 bp with a polyaden-
ylation signal and a polyA tail (Genbank No. AF082075)
(Fig. 2 A). By fluorescence in situ hybridization, this new
gene, termed bIV spectrin, was localized on human chro-
mosome 19q13.13 and on the synthenic region on mouse
chromosome 7b2 (not shown). Through BLAST analysis,
we matched the cDNA of bIV spectrin to a genomic
sequence from human chromosome 19 in the HighBerghs et al. bIV Spectrin 989
Throughput Genomic Sequence database (Genbank No.
AC021625). Comparison of this genomic sequence, which
corresponds to a first draft of 34 unordered pieces, with
the cDNA of bIV spectrin revealed that the latter is gener-
ated from 36 exons (Fig. 2 B). All exons, except for exon
17, are found in this genomic sequence and are flanked by
canonical donor/acceptor intron sites. This genomic region
still contains many gaps of unknown length, which may ac-
count for the apparent absence of the exon 17 (bp’s 3819–
4021) found in the cDNA sequences.
A high degree of similarity was found between portions of
the bIV spectrin cDNA and another genomic sequence of
100 unordered pieces from chromosome 16 (Genbank No.
AC009140.4). This genomic draft contains 18 sequences that
are bounded by donor/acceptor intron sites and are very con-
served with 18 exons of bIV spectrin (exons 1, 8–11, 13, 15–
17, 19, 25, 26, 28, 29, 32, 34–36) (not shown). This genomic
draft, however, did not appear to include the remaining ex-
ons of bIV spectrin. Our cDNA contig for bIV spectrin and
the genomic sequence on chromosome 19 only differed in
three base pairs, possibly because of polymorphism or se-
quencing artifacts. In contrast, six of the bIV spectrin-related
exons on chromosome 16 contained many base substitutions,
deletions, or insertions compared with the related exons in
bIV spectrin. These data confirmed that our cDNA contig
was entirely derived from the bIV spectrin gene on chromo-
Figure 1. (A) Schematic representation
of human ICA512. The protein in-
cludes 979 amino acids, including a
signal peptide (SP), a single trans-
membrane domain (TMD), and a cyto-
plasmic domain with an inactive PTP
domain. Cleavage at a consensus site
for furin-like convertases between
amino acids 448 and 449 (arrow) gives
rise to an NH2-terminal fragment and a
transmembrane fragment of 60–66 kD
that includes the cytoplasmic domain.
CHO, glycosylation sites. The residues
in the PTP domain of ICA512 that dis-
tinguish it from active PTPs are indi-
cated (A877, D911). (B–F) Interaction
of the partial clone of bIV spectrin, B8,
with ICA512cyt. (B and C) Yeast two-
hybrid mating assay. L40 cells trans-
formed with the prey plasmid pACTII-
B8 were mated with AMR70 cells
transformed with bait plasmids pLexA-
ICA512cyt, pLexA-ICA512cyt AD/
DA, pLexA-PHOGRINcyt, pLexA-
lamin, or pLexA-MSS4 and grown on
selective media in the absence (B) and
presence (C) of 2 mM 3-AT. Cell sur-
vival reflects the interaction of the bait
with the prey. (D and E) Expression
levels of the different baits and B8 in
L40-AMR70 mated cells as determined
by Western blotting with an antiserum
against LexA (D) and HA (E). (F)
Coimmunoprecipitation of ICA512 and
B8 from cotransfected COS cells.
A mouse antibody directed against
ICA512cyt or a rabbit antibody di-
rected against the bIV spectrin specific
domain (bIV-SD) were used for immu-
noprecipitation (IP) from Triton X-100
extracts of nontransfected (NT) and
ICA512-B8 cotransfected (T) cells. Im-
munoprecipitates were Western blotted
(WB) with affinity purified antibodies
directed against the ectodomain of
ICA512,  bIV-SD, or a mouse antibody
directed against HA. The arrows point
to the immunoprecipitated ICA512
transmembrane fragment (ICA512
TMF) and B8, while a bracket indicates
the position of pro-ICA512.The Journal of Cell Biology, Volume 151, 2000 990
some 19. They also suggested, on the other hand, that a gene
closely related to bIV spectrin resides on chromosome 16.
Cloning and characterization of this gene, provisionally
termed  bVI spectrin, is in progress.
The conceptual translation of the bIV spectrin cDNA
corresponds to a protein of 2,559 amino acids with a pre-
dicted molecular weight of z288 kD and an isoelectric
point of z5.9. The putative starting methionine of bIV
spectrin is not in the context of a Kozak sequence, but it
is preceded in the 59-untranslated region by an in-frame
stop codon. The domain structure of bIV spectrin closely
resembles that of other b spectrins (Hu et al., 1992;
Figure 2. (A) Schematic diagram of the overlapping human bIV spectrin cDNAs forming the total contig of 8,789 bp. Additional clones
that did not affect the contig have been left out of the alignment. (B) Graphical representation of the genomic organization of bIV spectrin.
Black boxes represent the 36 exons encoding the full-length bIV spectrin. Exons from alternative spliced isoforms are boxed in grey. The
length of the intervening sequences is still undetermined. Translation initiation and stop codons of the four alternative spliced variants are
indicated. (C) Schematic representation of the domain structure of bIVS1 spectrin. CH, calponin-homology. (D) Primary amino acid se-
quence of bIVS1 spectrin. The four major domains of bIVS1 spectrin, numbered I–IV, are boxed. Domain I: the residues in the calponin-
homology domain are in bold. Domain II: the arabic numbers on the left correspond to the spectrin repeats. Within this domain, the pre-
dicted A, B, and C helices are boxed separately and their conserved charged and aromatic residues are in bold. The glycine-rich region of
15 residues following the predicted A helix of spectrin repeat 4 is shown as an insert. Domain III: the four ERQES repeats in this specific
domain are in bold. Domain IV: the residues in the pleckstrin homology domain are in bold. The proline-rich regions in spectrin repeat 15
and in the specific domain are underlined. (E) An alignment of the third ERQES repeat within the specific domain of bIV spectrin with se-
quences in the spectrin repeat 1 of bII and bIII spectrin. (F) Schematic representation of the different isoforms of bIV spectrin. (Top inset)
The amino acids at the boundary between exons 17 and 18 in bIVS1 spectrin. (Middle inset, bold) The residues encoded by exon 17B in
two distinct reading frames. The top sequence is in frame with the preceding exon 17 and includes a stop codon. The bottom sequence be-
gins with a methionine and is in frame with the following exon 18. (Bottom inset) The amino acid sequence of exon 30B at the COOH ter-
minus of bIVS4 spectrin. The roman numbers I–IV indicate the four major domains of bIV spectrin as defined in Fig. 2 D.Berghs et al. bIV Spectrin 991
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Winkelmann et al., 1990a,b; Ma et al., 1993; Ohara et al.,
1998), with the exception of bV spectrin (Stabach and
Morrow, 2000). It includes two calponin homology do-
mains, followed by 16 complete spectrin repeats, a partial
spectrin repeat (repeat 17), and a PH domain (Fig. 2, C
and D). Calponin homology domains are found at the
NH2 terminus of many proteins, including b spectrins,
and mediate the interaction with actin (Karinch et al.,
1990; Frappier et al., 1992; Banuelos et al., 1998). Each of
the first 16 spectrin repeats of bIV spectrin follows the
criteria defined for the repeat 14 of Drosophila b spectrin
(Yan et al., 1993; Pascual et al., 1997), and thus is pre-
dicted to assemble into three helices termed A, B, and C
(Fig. 2 D). The repeat 15 of bIV spectrin, which in other
b spectrins binds ankyrins (Kennedy et al., 1991), is 43.8,
46.7, and 31.4% identical to the corresponding repeats of
bI,  bII, and bIII spectrin, respectively. Unlike typical
spectrin repeats, but similar to repeat 15 of other b spec-
trins, it does not include a tryptophan at position 17 in
the helix A (Fig. 2 D). As in all other b spectrins, the re-
peat 17 of bIV spectrin lacks the segment corresponding
to the C helix (Fig. 2 D). This is consistent with the possi-
bility that the A and B helices of repeat 17 of bIV spec-
trin form a three-helix bundle with the lone C helix at the
NH2 terminus of an a spectrin (Kennedy et al., 1994;
Deng et al., 1995). The putative loop between the pre-
dicted helices A and B of repeat 4 contains a stretch of 15
residues that is not found in other b spectrins (Fig. 2 D).
This insert is rich in glycines, consistent with a role as a
helix breaker.
The region of 294 residues between the repeat 17 and
the PH domain is specific for bIV spectrin as it shows no
similarity with regions present in other b spectrins. This
domain is rich in prolines (15% of the residues), is very ba-
sic (pI: 10.5), and contains a motif of five residues (ER-
QES) that is repeated four times within a stretch of 90 res-
idues (residues 2220–2309, henceforth defined as ERQES
domain). An identical motif was not found in any other
protein in public databases. The ERQES domain is highly
charged (55.5% charged residues) because of its high con-
tent in glutamate (23.3%), glutamine (8.8%), and arginine
(26.6%). The presence of only two aspartates (2.2%) and
the absence of asparagines and lysines, however, indicates
that there is a strong bias toward specific residues in this
region. The equal spacing of 13 residues between the ER-
QES repeats 1–3 further suggests the repetitive nature of
this domain. Interestingly, the sequence corresponding to
the third ERQES repeat and the four following residues
(ERQESAEHE) is 77% identical to the sequence ERLE-
KAEHE within spectrin repeats 1 of human bII (residues
397–405) and bIII (residues 400–408) spectrin (Fig. 2 E).
The motif ERLEKAEHE is part of a domain that associ-
ates bII spectrin with membranes, presumably via pro-
tein–protein interaction (Davis and Bennett, 1994; Lom-
bardo et al., 1994). Prediction of the secondary structure of
bIV spectrin suggests that the ERQES domain is exposed
at the protein’s surface (not shown) and, as such, might
also engage in protein–protein interaction.
bIV spectrin contains numerous putative SH3 binding
sites (Fig. 2 D). Two of these proline-rich motifs (residues
1859–1864 and 2405–2411) are adjacent to putative mem-
brane association domains. Specifically, the first of these
motifs precedes the putative B helix in repeat 15, which
may act as an ankyrin-binding site, while the second motif
precedes the PH domain. The PH domain of bIV spectrin
is very conserved with the corresponding domains in bIS2,
bII, and bIII spectrins and is therefore likely to bind phos-
phoinositides, such as phosphatidylinositol 4,5 bisphos-
phate (Hyvonen et al, 1995).
bIV Spectrin Is Alternatively Spliced
Our data indicated that bIV spectrin undergoes alternative
splicing. Specifically, one cDNA clone of z2.4 kb con-
tained an insert of 88 bp between exon 17 and 18, which
was not present in overlapping cDNA clones (Fig. 2 F).
This insert was also found in the bIV spectrin gene, where
it is flanked by canonic donor and acceptor splice sites at its
59 and 39 ends. Insertion of this exon, termed 17B (Fig. 2, B
and F), introduces a stop codon in the open reading frame
of bIV spectrin, thereby causing its termination in spectrin
repeat 9. The conceptual translation of this cDNA corre-
sponds to a polypeptide of 1,302 amino acids with a pre-
dicted molecular weight of z145 kD. In a different reading
frame, on the other hand, exon 17B encodes for a methion-
ine that is preceded by a stop codon in exon 17 and is in
frame with the remaining COOH-terminal portion of bIV
spectrin (Fig. 2, B and F). Recognition of this methionine
as a novel initiation site for translation would generate an
additional polypeptide of 1,307 amino acids with an ex-
pected molecular weight of z149 kD. It is conceivable that
the inclusion of exon 17B gives rise to a bicistronic mRNA,
whose translation produces two different bIV spectrin pro-
teins. Based on the established nomenclature for spectrins
(Winkelmann and Forget, 1993), the originally cloned bIV
spectrin has been termed bIVS1 spectrin, and hence we
will refer to these two variants as bIVS2 and bIVS3 spec-
trin (Genbank No. AY004226).
In an additional clone, an insert of 315 bp (exon 30B)
followed exon 30 (Fig. 2, B and F). This insert encodes 42
amino acids and a stop codon, contains a polyadenylation
site, and was found in the bIV spectrin gene, where it is
flanked by canonic 59 and 39 splice sites. The isoform in-
cluding this exon corresponds to a polypeptide of 2,149
amino acids (expected molecular weight: z242 kD), which
contains the calponin-homology domain and all 17 spectrin
repeats, but lacks the specific domain and the PH domain
(Fig. 2 F). This isoform has been termed bIVS4 spectrin
(Genbank No. AY004227). A search in publicly available
databases revealed the presence of a partial cDNA clone
(Genbank No. AL133093) of 1,444 bp from human testis
that is 100% identical to bIV spectrin in the region corre-
sponding to nucleotides 4850–6082, but differs from it in
the remaining 211 bp at the 39 end. This divergent se-
quence encodes 30 residues, followed by a stop codon and
a polyA stretch of 109 bp. On chromosome 19, however,
the 102 bp preceding the polyA stretch are found immedi-
ately after exon 27 of bIV spectrin, where they are not pre-
ceded by a canonic 59 splice site. Furthermore, this se-
quence does not contain a polyadenylation signal. Thus,
this clone includes a part of the intron following exon 27.
Expression of bIV Spectrin mRNAs 
The expression of bIV spectrin was analyzed by Northern
blotting on polyA1 RNA from various human tissues using
a 324 bp probe within the region encoding for the specificBerghs et al. bIV Spectrin 993
domain common to bIVS1 and bIVS3 spectrin. This probe
hybridized with three transcripts of z9.0, z5.1, and z3.1
kb, all of which were predominantly expressed in brain
(Fig. 3 A). The relationship of these transcripts with bIV
spectrin was suggested by their detection with a distinct
probe derived from the 39 untranslated region of bIV spec-
trin (not shown). A mRNA of z9.0 kb is in good agree-
ment with the size of the bIVS1 spectrin cDNA. Both the
z9.0 and the z5.1 kb transcripts were also detected in var-
ious regions of the rat brain, including cerebellum, thala-
mus, midbrain, medulla, frontal, and posterior cortex and
hippocampus (data not shown). Weaker signals for the
z9.0-kb transcript were detected in human skeletal muscle
and kidney, while the z5.1-kb transcript was barely detect-
able in pancreas (Fig. 3 A). Since pancreatic islets account
for only z3% of the pancreas weight, we directly assessed
the expression of bIV spectrin on polyA1 RNA isolated
from purified human pancreatic islets. In pancreatic islets,
as in brain, the bIV spectrin probe hybridized with three
transcripts of z8.5, z4.2, and z2.3 kb (Fig. 3 C). The ex-
pression of bIV spectrin in pancreatic islets was confirmed
by the amplification by PCR from mouse islets of a prod-
uct whose cDNA (Genbank No. AF203696) was 98%
identical to nucleotides 4223–4665 of human bIV spectrin.
bIV Spectrin Proteins in Brain and Pancreatic Islets 
We further analyzed by Western blotting the expression of
bIV spectrin in brain and pancreatic islets, tissues that are
enriched in ICA512. To this end, we used two affinity-
purified antibodies directed against peptides encoding
amino acids 2237–2256 in the specific domain (bIV-SD)
and 2542-2559 at the COOH terminus (bIV-CT) of bIVS1
spectrin. These peptides were chosen on the basis of their
predicted antigenicity and because they share no signifi-
cant homology with sequences in other a and b spectrins.
Both antibodies reacted by Western blotting with the bIV
spectrin fragment B8 transiently expressed in COS cells
(Fig. 1 F, and not shown). The bIV-CT antibody recog-
nized two proteins of z250 and 160 kD in rat brain PNS
and total extracts of purified human islets (Fig. 4 A), while
it detected an additional protein of z140 kD in rat brain
only (Fig. 4, A and B). Preincubation of the bIV-CT anti-
body with the antigenic peptide blocked its binding to
these three proteins, supporting their relationship with
bIV spectrin (Fig. 4 A). Taking into account the aberrant
electrophoretic mobility displayed by all known spectrins
(Zagon et al., 1984; Ohara et al., 1998; Stankewich et al.,
1998), the z250-kD protein might correspond to bIVS1
spectrin, which has a predicted molecular weight of z288
kD. The identity of the z160- and z140-kD proteins re-
mains to be established. Accordingly, we will provisionally
refer to these proteins as bIV spectrin 160 and 140. The
bIV-SD antibody produced a similar immunoblot pattern
(Fig. 4 B), consistent with the possibility that the z250-,
z160-, and z140-kD proteins originate from the bIV
spectrin gene. The bIV-SD antibody, however, recognized
much less prominently bIV spectrin 160 in brain, and even
less in islets (Fig. 4 B). The peptide used to raise the bIV-
SD antibody is located within the ERQES domain and
contains several optimal consensus sites for serine phos-
phorylation. We asked therefore whether the limited reac-
tivity of the bIV-SD antibody toward bIV spectrin 160
could result from the phosphorylation of its epitope within
this protein. Evidence that treatment of rat brain PNS with
alkaline phosphatase dramatically enhanced the reactivity
of the bIV-SD antibody toward bIV spectrin 160 (Fig. 4 B)
corroborated this hypothesis. The labeling of bIVS1 spec-
trin and bIV spectrin 140, on the other hand, was unaf-
fected. As expected, the reactivity of the bIV-SD antibody
Figure 3. Northern blots for bIV spectrin on
polyA1 RNA from various human tissues (A)
and purified human pancreatic islets (C). (B)
Autoradiography on the same filter as in A after
hybridization with the control probe for b-actin.
Heart and skeletal muscle express two b-actin
mRNAs of z2 and 1.6–1.8 kb. The Journal of Cell Biology, Volume 151, 2000 994
was completely blocked by the incubation with its immu-
nogenic peptide (Fig. 4 B).
bIV Spectrins Have Different Biochemical Properties
Upon subcellular fractionation of brain homogenates, both
bIVS1 spectrin and bIV spectrin 140 were recovered in the
HSP, while bIV spectrin 160 was distributed between the
HSS and the HSP (Fig. 5 A). Virtually all bIVS1 spectrin
partitioned in the HSP detergent-insoluble material (Fig. 5,
A and B). bIV spectrin 160 and 140, on the other hand,
were found in both the HSP detergent soluble and insolu-
ble fractions (Fig. 5, A and B). Notably, the pools of bIV
spectrin 160 in the HSS and HSP detergent soluble fraction
did not react with the bIV-SD antibody (Fig. 5 B), unless
these fractions were preincubated with alkaline phos-
phatase (Fig. 5 C). These data suggest that phosphorylation
of the ERQES domain is associated with the solubilization
of bIV spectrin 160 and its dissociation from membranes.
Treatment of the PNS with alkaline phosphatase did not af-
fect the subcellular distribution of bIVS1 spectrin, but al-
lowed an increased recovery of bIV spectrin 140 in the
HSP-soluble fraction (Fig. 5 D). This treatment also re-
sulted in a shift of most of bIV spectrin 160 from the HSP
to the HSS (Fig. 5 D). Taken together, these results suggest
that the interaction of bIV spectrins with cytoskeletal and/
or membrane proteins is modulated by phosphorylation.
Figure 4. (A) Western blotting with the affinity-purified anti-
body against a COOH-terminal peptide of bIV spectrin (bIV-
CT) on 50 mg protein from rat brain PNS (brain, lanes 1 and 3)
and homogenates of human pancreatic islets (islets, lanes 2 and
4). In the case of islets, the bIV-CT antibody was incubated with
an excess of the immunogenic peptide before its incubation with
the nitrocellulose strips. (B) Western blotting with the affinity-
purified antibody against a peptide in the specific domain of bIV
spectrin (bIV-SD) on 50 mg protein from rat brain PNS (brain,
lanes 1, 3, and 4) and homogenates of human pancreatic islets (is-
lets, lanes 2 and 5). (brain 1 alk. phos., lane 3) Rat brain PNS was
treated with calf intestine alkaline phosphatase for 1 h at 378C.
(lanes 4 and 5) Western blotting with the bIV-SD antibody after
preincubation with its antigenic peptide.
Figure 6. Double immunolabeling of V5-tagged COOH-terminal
domains of human bIS2 (A and B), bIIS1 (C and D), bIII (E and
F), and bIVS1 (G and H) spectrins with the V5 (left) and bIV-CT
(right) antibodies in transiently transfected CHO cells. Bar, 25 mm.
Figure 5. Equal volumes of rat brain subcellular fractions immuno-
blotted with bIV-CT (A and D) or bIV-SD (B and C) antibodies.
(C) Fractions were treated with alkaline phosphatase before immu-
noblotting. (D) The PNS was treated with alkaline phosphatase be-
fore fractionation. HSP-S, HSP-detergent soluble material. HSP-IS,
HSP detergent-insoluble material.Berghs et al. bIV Spectrin 995
Localization of bIV Spectrin in Pancreatic Islets
To rule out the possibility that our anti-bIV spectrin anti-
bodies would recognize other b spectrins by immunocy-
tochemistry, both antibodies were employed for the stain-
ing of CHO cells transiently transfected with V5-tagged
COOH-terminal domains of bIS2 (amino acids 2117–
2328),  bIIS1 (2140–2365), bIII (amino acids 2154–2390),
or bIVS1 spectrin (2222–2559). All four spectrin frag-
ments were recognized by the anti-V5 mouse monoclonal
antibody and partitioned, albeit to a different extent, be-
tween the cytosol and the nucleus of transfected cells (Fig.
6 A). Conversely, the bIV-CT (Fig. 6 A) and bIV-SD (not
shown) antibodies only stained CHO cells expressing the
COOH-terminal region of bIVS1 spectrin.
The tissue and intracellular distribution of bIV spec-
trin was then investigated by confocal microscopy using
the bIV-CT antibody. In rat pancreas, bIV spectrin im-
munoreactivity was restricted to pancreatic islets. Like
ICA512, bIV spectrin was detected in both the insulin-
secreting b cells as well as in the surrounding a cells that
secrete glucagon (Fig. 7, A–F). In b cells, there was a fine
punctate staining throughout the cytoplasm (not shown).
A more intense cytoplasmic labeling was observed in the a
cells (Fig. 7, A–F), often in correspondence of rod-like
perinuclear structures of several micrometers in length
(Fig. 7 G). These organelles did not significantly overlap
with secretory granules, as shown by double labeling for
glucagon (Fig. 7 H). The specificity of this staining was
suggested by its complete disappearance when the bIV-
CT antibody was preincubated with its antigenic peptide
(Fig. 7. I). b Spectrins are known to associate with various
intracellular compartments, including the Golgi complex,
endosomes, and lysosomes (Devarajan et al., 1997; Hoock
et al., 1997; Beck and Nelson, 1998). Thus, we compared
the distribution of bIV spectrin with that of these various
organelles in a cells. There was no significant colocaliza-
tion of bIV spectrin with g-adaptin and TGN38, two mark-
ers of the trans-Golgi network, with the endosomal mark-
ers transferrin receptor and early endosomal antigen-1 or
with the lysosome marker lgp120 (not shown). Thus, the
identity of the bIV spectrin-immunoreactive structures in
pancreatic islets remains to be established.
bIV Spectrin Is Present at the Axon Initial Segments 
and Nodes of Ranvier in the Central and Peripheral 
Nervous System
In brain, expression of bIV spectrin was first examined by
in situ hybridization on adult rat brain sections using an
antisense riboprobe corresponding to the partial bIV spec-
trin clone B8. The highest levels of expression were de-
tected in the cell bodies of large myelinated neurons, such
as pyramidal neurons of the hippocampus, granule cells of
the dentate gyrus, and Purkinje cells of the cerebellar cor-
tex (Fig. 8). No signal was detected in nonneuronal cells,
Figure 7. Confocal microscopy
for  bIV spectrin (pseudo green),
and insulin or glucagon (pseudo
red) in rat pancreas. (A and B)
Staining of a pancreatic islet for
bIV spectrin (A) and insulin
(B). (C) Merge of A and B. (D
and E) Staining of a pancreatic
islet for bIV spectrin (D) and
glucagon (E). (F) Merge of D
and E. (G and H) High magnifi-
cations of pancreatic islet a cells
stained either for bIV spectrin
alone (G) or both bIV spectrin
and glucagon (H). (I) The bIV-
CT antibody was incubated with
an excess of the antigenic pep-
tide before the incubation with
the tissue sections. Bars, 100 mm
(A–F), 10 mm (G–I).The Journal of Cell Biology, Volume 151, 2000 996
including glial and endothelial cells. Likewise, no signal
was detected on sections incubated with the corresponding
control sense riboprobe (not shown). 
By immunocytochemistry on rat brain sections, the bIV-
CT antibody produced a strong labeling of pyramidal neu-
rons in the cerebral cortex and the hippocampus, granule
cells of the dentate gyrus, and Purkinje cells in the cerebel-
lum (Fig. 9, and data not shown). This immunolabeling
was most prominent in the axon initial segments (Fig. 9, A,
D, and G) and nodes of Ranvier (D and H), while no
staining was observed in the myelinated internodal seg-
ments, as visualized with an antibody against myelin basic
protein (Fig. 9, B and C). A fine granular staining reminis-
cent of the labeling observed in pancreatic islets was ap-
preciable in the perikarya of Purkinje cells (Fig. 9 A). No
immunoreactivity was detected in dendrites, axon termi-
nals, glial cells, or blood vessels. The specificity of this la-
beling was supported by the absence of staining in sections
incubated with the corresponding rabbit preimmune se-
rum (not shown) and by the ability of the antigenic pep-
tide to compete with endogenous bIV spectrin for the
binding of the bIV-CT antibody (not shown). Immunocy-
tochemistry on dissociated myelinated fibers from the rat
sciatic nerve showed that, like in the central nervous sys-
tem, bIV spectrin is concentrated at the nodes of Ranvier
in the peripheral nervous system (Fig. 9 I).
Previous studies demonstrated that, in neurons, the anky-
rinG 480/270-kD isoform (also known as ankyrin3) is selec-
tively concentrated at initial segments and nodes of Ranvier
(Kordeli et al., 1990, 1995; Peters et al., 1995). Here, it is in-
volved in the clustering of the voltage-gated Na1 channels
that generate the saltatory action potentials (Zhou et al.,
1998). Double immunostaining for bIV spectrin and anky-
rinG 480/270 showed a perfect overlap of the two proteins at
Figure 8. In situ hybridiza-
tion for bIV spectrin on rat
brain (dark field images). (A)
CA3 region of the hippocam-
pus, (B) dentate gyrus, (C)
cerebellar cortex. Bars, 100
mm (A and B), 50 mm (C).
Figure 9. Confocal microscopy
for  bIV spectrin (pseudo green)
and myelin basic protein or
ankyrin G480/270-kD (pseudo
red) in rat brain. (A and B)
Staining of the cerebellar cortex
for bIV spectrin (A) and myelin
basic protein (B). (C) Merge of
A and B. The arrow points to
the boundary between the initial
segment and the internodal seg-
ment of a Purkinje cell myelin-
ated axon. (D and E) Staining of
the hippocampus for bIV spec-
trin (D) and ankyrinG 480/270-
kD (E). (F) Merge of D and E.
(G) High power magnification
of axon initial segments in the
cerebral cortex costained for
bIV spectrin and ankyrinG. (H)
High power magnification of
nodes of Ranvier in the cerebel-
lum costained for bIV spectrin
and ankyrinG. (I) Staining of
teased nerve preparation with
bIV spectrin and ankyrinG 480/
270. Bars, 40 mm (A–C), 100 mm
(D–F), 5 mm (H–I).Berghs et al. bIV Spectrin 997
initial segments (Fig. 9, D–F) and central (H) and periph-
eral (I) nodes of Ranvier. These data raise the possibility
that bIV spectrin and ankyrinG 480/270 bind each other in
the brain as well as the peripheral nervous system. 
The bIV Spectrin Isoform Localized at the Axon Initial 
Segments Is bIVS1 Spectrin
Next, we investigated the expression of bIV spectrin dur-
ing brain development. By Western blotting, bIVS1 spec-
trin was first detected at embryonic day 19 and its expres-
sion level progressively increased until adult age (Fig. 10).
bIV spectrin 140 appeared only after birth and, similar
to bIVS1 spectrin, it was maximally expressed in the adult.
bIV spectrin 160, instead, was already present at embry-
onic day 10, and its level appeared constant throughout
development. These data further suggested that bIV spec-
trin 160 is not a proteolytic fragment of bIVS1 spectrin. 
The expression of bIV spectrin during brain development
was also investigated by immunocytochemistry (Fig. 11). A
weak immunoreactivity for bIV spectrin was detectable in
the neurons of the developing hippocampus at embryonic
day 15, but there was no staining reminiscent of axon initial
segments (Fig. 11 A). By embryonic day 19, however, the
initial segments were clearly labeled both in the cortex and
the hippocampus (Fig. 11 B). Many more initial segments
positive for bIV spectrin were present by postnatal day 10
in both regions (Fig. 11 C, and data not shown), with maxi-
mum immunoreactivity in the adult brain (D). Taken to-
gether, these data suggested that bIVS1 spectrin is the spe-
cific isoform localized at axon initial segments.
Discussion
In this study, we have identified a novel spectrin gene in
human, termed bIV spectrin, that is localized on chromo-
some 19q13.13. The longest product of this gene, termed
bIVS1 spectrin, includes 36 exons and corresponds to a
protein of 2,559 amino acids, whose domain structure
closely resembles that of other b spectrins (for review, see
Bennett and Gilligan, 1993; Goodman et al., 1995; Viel
and Branton, 1996). Specifically, bIVS1 spectrin contains
two calponin-homology domains at its NH2 terminus and
may therefore associate with F-actin and protein 4.1. Simi-
lar to other b spectrins, it may also interact with ankyrin
through spectrin repeat 15 and with an a spectrin via its
partial spectrin repeat 17, whereas its COOH-terminal PH
domain could bind phospholipids. bIVS1 spectrin also
contains a specific domain between its partial spectrin re-
peat 17 and the PH domain. This very basic domain in-
cludes several putative SH3 binding sites and a unique
ERQES domain in which there is a sequence of significant
similarity with a motif within the membrane association
domain of bII and bIII spectrin (Davis and Bennett, 1994;
Lombardo et al., 1994). Thus, this specific domain could
mediate the interaction of bIVS1 with other proteins.
The apparent size of the bIVS1 spectrin transcript was
z9.0 kb in brain and z8.5 kb in pancreatic islets. In both
Figure 10. Temporal expres-
sion of bIV spectrin during
brain development. Western
blotting with the bIV-CT an-
tibody on PNS (40 mg pro-
tein) from rat brain at embry-
onic day 10 (E10), 15 (E15),
19 (E19), postnatal day 1
(P1), 10 (P10), and adult age.
Figure 11. Appearance of bIV spectrin immu-
noreactivity at axon initial segments during brain
development. Confocal microscopy with the bIV-
CT antibody (pseudo green) on sections from rat
brain at embryonic day 15 (A), 19 (B), postnatal
day 10 (C), and adult age (D). Bars, 50 mm.The Journal of Cell Biology, Volume 151, 2000 998
tissues, however, bIVS1 spectrin was detected as a protein
of 250 kD. The small discrepancy in the size of the tran-
scripts may result therefore from tissue-specific differ-
ences in the untranslated region or from variations in the
laboratory procedures, as the blot of human islets was pre-
pared in our laboratory, while the blot including the brain
sample was acquired from a commercial source. 
Similar to other b spectrins, the bIV spectrin gene un-
dergoes alternative splicing. Specifically, we have identi-
fied three bIV spectrin splice variants in addition to bIVS1
spectrin. Two of these isoforms, bIVS2 and bIVS3 spec-
trin, originate from one messenger that contains an addi-
tional exon (exon 17B) between exons 17 and 18 of bIVS1
spectrin. The predicted amino acid sequences of bIVS2
and bIVS1 spectrin are identical up to the middle of the C
helix in repeat 9. The sequence corresponding to the last 23
residues of bIVS2 spectrin is unique and does not follow
the consensus for spectrin repeats, as it is very rich in pro-
lines (6/23 amino acids). Accordingly, the last repeat of
bIVS2 spectrin (repeat 9) is not complete, and contains
only helices A and B. This observation raises the intriguing
possibility that this partial repeat, similar to the partial re-
peat 17 of other b spectrins, including bIV spectrin, inter-
acts with the lone C helix at the NH2 terminus of an a spec-
trin. An alternative possibility is that this partial repeat
interacts in a head-to-tail fashion with the NH2-terminal
domain of bIVS3 spectrin. Specifically, the first 19 amino
acids of bIVS3 encoded by exon 17 cannot be part of an a
helix because they include six prolines. The next 10 amino
acids together with the following 15 residues encoded by
exon 18, however, are predicted to form a coiled-coil do-
main (Lupas et al., 1991). Similar to the partial NH2-termi-
nal repeat of a spectrin, this domain contains an arginine at
position 8, a residue that is thought to interact with resi-
dues 7 and 29 in helices A and B, respectively (Yan et al.,
1993). This domain of bIVS3 spectrin could therefore be
equivalent to the single C helix at the NH2 terminus of an a
spectrin and pair with the predicted A and B helices at the
COOH terminus of bIVS2 spectrin. The fourth bIV spec-
trin isoform, termed bIVS4 spectrin, extends only 42 resi-
dues beyond the partial repeat 17, because of the insertion
of an additional exon (exon 30B) that contains an in-frame
stop codon. Thus, bIVS4 spectrin, similar to bIS1 (Wink-
elmann et al., 1990b) and bIIS2 (Hayes et al., 2000) spec-
trin, does not include a PH domain. 
Both the bIV-SD and bIV-CT antibodies are directed
against peptides that are not found in bIVS2 and bIVS4
spectrin. Thus, the biochemical properties and localization
of these isoforms remain to be determined. Both antibod-
ies, on the other hand, recognize two proteins of 160 and
140 kD. bIV spectrin 160 and 140 show significantly differ-
ent properties than bIVS1 spectrin. For instance, treat-
ment of the PNS with alkaline phosphatase increased the
pool of bIV spectrin 160 recovered in the HSS, and en-
hanced the detergent extractability of bIV spectrin 140.
Conversely, bIVS1 spectrin partitioned in all conditions in
the HSP detergent insoluble material. Furthermore, bIV
spectrin 140 was detected in brain, but not in islets. Finally,
the temporal expression of bIV spectrins 160 and 140 dur-
ing brain development was different from that of bIVS1
spectrin. These data suggest that bIV spectrin 160 and 140
are not proteolytic fragments of bIVS1 spectrin. 
We have shown that the reactivity of the bIV-SD anti-
body with bIV spectrin 160 is significantly enhanced upon
alkaline phosphatase treatment. Specifically, upon subcel-
lular fractionation, this antibody reacts with the pool of
bIV spectrin 160 recovered in the HSP detergent-insolu-
ble material, but not with the pool present in the HSS and
HSP detergent-soluble material, unless these fractions are
incubated with alkaline phosphatase before immunoblot-
ting. Since the antigenic peptide of the bIV-SD antibody
contains an optimal consensus sequence for phosphoryla-
tion, these data suggest that the antigenic epitope within
the ERQES domain is phosphorylated in vivo and that
phosphorylation at this site affects the association of bIV
spectrin 160 with membranes. This possibility is consistent
with previous studies indicating that an increased phos-
phorylation of b spectrin during mitosis is associated with
its redistribution from the detergent-insoluble to the de-
tergent-soluble fraction and its dissociation from mem-
branes (Fowler and Adam, 1992).
Like ICA512, bIV spectrin is enriched in pancreatic is-
lets and brain. In the a cells, bIV spectrin’s immunoreac-
tivity is concentrated in the cytosol, most often in peri-
nuclear, rod-like structures. This compartment did not
significantly overlap with the Golgi, endosomes, or lyso-
somes, three organelles along the secretory pathway where
b spectrins have been found (Beck and Nelson, 1998; De
Matteis and Morrow, 1998). Thus, its identity remains to
be determined. In rat brain and teased fibers of the sciatic
nerve, bIV spectrin is concentrated at the axon initial seg-
ments and the nodes of Ranvier. bIV spectrin is the first
spectrin that is selectively enriched in these specialized do-
mains, in both the central and the peripheral nervous tis-
sue. bII spectrin is present both in axons and synaptic ter-
minals (Riederer et al., 1986; Zagon et al., 1986; Trapp et
al., 1989), while bIS2 spectrin is found in neuronal cell
bodies, dendrites (Riederer et al., 1986; Zagon et al., 1986;
Malchiodi-Albedi et al., 1993), and post-synaptic densities
(Malchiodi-Albedi et al., 1993). bIII spectrin is also ex-
pressed in brain, where it is enriched in dendrites (Ohara
et al., 1998; Stankewich et al., 1998). Taken together, these
data suggest a role for b spectrins as potential organizers
of different neuronal microdomains. 
The axon initial segments and the nodes of Ranvier
share a common molecular organization and may have
evolved from a common precursor (Davis et al., 1996).
Both compartments are characterized by an electron-
dense cytoskeletal matrix beneath the axolemma (Matsu-
moto and Rosenbluth, 1985) and by a 40-fold enrichment
of voltage-gated sodium channels (Ritchie and Rogart,
1977), whose opening triggers the generation of action po-
tentials and their conduction from one node to the next.
Other proteins enriched at these sites are the cell adhesion
molecules neurofascin and NrCAM (Davis et al., 1996),
ankyrinG 480/270-kD (Kordeli et al., 1995; Lambert et al.,
1997), and an amphiphysin II–like protein (Butler et al.,
1997). The repeat 15 of bIV spectrin is similar to the corre-
sponding ankyrin-binding repeat in bI and bII spectrins
(Kennedy et al., 1991). In view of their colocalization at
initial segments and nodes of Ranvier, it seems plausible
that bIV spectrin and ankyrinG are associated and to-
gether mediate the anchoring of nodal membrane proteins
to the actin cytoskeleton. Berghs et al. bIV Spectrin 999
In the developing rat hippocampus, the immunoreactiv-
ity for bIV spectrin at the initial segments first appears at
embryonic day 19 and progressively increases thereafter.
This pattern closely resembles the developmental expres-
sion profile of bIVS1 spectrin in rat brain. A similar corre-
lation may exist between the appearance of bIV spectrin
140 at postnatal day 10 and the progressive development
of nodes of Ranvier during myelination after birth. The
initial segments and the nodes of Ranvier play a similar
role in the initiation and propagation of action potentials.
Initial segments, in addition, act as barriers that prevent
lateral diffusion of membrane proteins and entry of vari-
ous organelles, including rough endoplasmic reticulum,
Golgi complex, and lysosomes into axons, while allowing
the progression of others, such as mitochondria and secre-
tory vesicles. Although the molecular foundation of this
selective diffusion barrier remains unknown, there is evi-
dence that the actin cytoskeleton is essential in its estab-
lishment and maintenance (Winckler et al., 1999). Thus,
the localization of bIVS1 spectrin and bIV spectrin 140 at
initial segments and nodes of Ranvier, respectively, could
correlate with the related and yet distinct functions of
these axonal compartments. It would be interesting to de-
termine whether a similar different localization occurs in
the case of the ankyrinG isoforms 480 and 270 kD.
We have identified bIV spectrin as an interactor of the
RPTP-like protein ICA512 in a two-hybrid screening in
yeast. The binding of ICA512 to the COOH-terminal do-
main of bIV spectrin has been confirmed by coimmuno-
precipitation from transfected fibroblasts. bIV spectrin
and ICA512 are both enriched in neurons and pancreatic
islets, but their intracellular localization is different. This
observation, however, does not preclude the possibility
that ICA512, at one stage of its intracellular route, inter-
acts with bIV spectrin. In steady state conditions, virtually
all ICA512 (Lee et al., 1998; Hermel et al., 1999; our un-
published observations) is found on secretory granules
(Solimena et al., 1996), while it is not detectable in other
compartments associated with the secretory and endocytic
pathways. Taking into account the fact that ICA512 has a
very short half life (Lee et al., 1998; Hermel et al., 1999;
our unpublished observations), it would be very difficult to
detect by immunocytochemistry a transient colocalization
of the two proteins in a compartment other than the secre-
tory granules. More sensitive assays for protein–protein
interaction in vivo, such as coimmunoprecipitation, were
precluded by the fact that virtually all bIVS1 spectrin and
most of bIV spectrin 140 and 160 partitioned in the HSP
detergent insoluble fraction. We have recently shown that,
in insulinoma cells, ICA512 is associated with b2 syntro-
phin (Ort et al., 2000). b2 syntrophin, in turn, interacts with
the spectrin-related protein utrophin. These data, consis-
tent with our previous studies (Hermel et al., 1999), sug-
gest that ICA512 is associated with the actin cytoskeleton.
Besides ICA512, the COOH-terminal domain of bIV
spectrin bound the cytoplasmic domain of the RPTP-
like molecule PHOGRIN (Wasmeier and Hutton, 1996).
PHOGRIN (also known as IA-2b, ICAAR, IAR, PTP-
NP, and PTPX) has many properties in common with
ICA512. Its cytoplasmic domain is 74% identical to the
corresponding region of ICA512, and also contains an as-
partate instead of an alanine in its inactive PTP “signature
motif.” Moreover, PHOGRIN is also enriched in the
secretory granules of neurons and peptide-secreting endo-
crine cells (Wasmeier and Hutton, 1996) and is a major
target of autoimmunity in type I diabetes (Lu et al., 1996).
ICA512 and PHOGRIN are not the only members of the
RPTP family that interact with spectrin-related molecules.
LAR, an RPTP expressed in numerous cell types including
neurons, interacts through its distal, “non-catalytic” PTP
domain with Trio, a protein that includes numerous spec-
trin repeats and two PH domains (Debant et al., 1996).
CD45, an RPTP involved in T and B cell signaling, binds
bII spectrin through its “inactive,” distal domain. Notably,
binding of spectrin increases the catalytic activity of its
proximal PTP domain (Lokeshwar and Bourguignon,
1992; Iida et al., 1994). Like the “inactive” PTP domains of
ICA512 and PHOGRIN, the distal PTP domain of CD45
includes an aspartate (D) rather than the obligatory ala-
nine (A) at position 12 from the catalytic cysteine of
canonic PTP domains. Overall, these data point to spec-
trin-related proteins as common binding partners of non-
catalytic PTP domains of RPTPs.
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